BioSpace News Archive

BioAgilytix Labs is pleased to announce the appointment of Marc Westermann to its commercial leadership team as Vice President of Business Development Europe. Westermann brings more than 25 years of senior corporate executive and commercial operations experience to BioAgilytix. He has a proven track record of leading performance wit

ImmunityBio, a privately-held immunotherapy company, today announced the results of a highly detailed computer-based molecular dynamics (MD) simulation, conducted in collaboration with Microsoft Corporation, that allowed visualization of the behavior of the SARS-CoV-2 “spike” protein.

Boston Scientific Corporation (NYSE: BSX) will participate in the virtually held 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 . Mike Mahoney , chairman and chief executive officer, will present at 8:20 a.m. EST . At approximately 8:40 a.m. EST , Mahoney will be joined by Dan Brennan , executive

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, today announced the appointment of Clare Grace, Ph.D., as the company’s first Chief Patient Officer. The appointment reflects the role of the patient as central to the company’s mission of keeping patients at the heart of all clinical trial activity. The appointm

Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug development, including the development of drugs for the trea

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. The fireside chat will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 AM Eastern Time on the Investors section of the Agile Therapeutics website at www.agiletherapeutics.com , und

Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew.

OrganaBio, LLC (“OrganaBio”) announces the launch of the ImmunoPAC™-T-CB T cell product, designed to support development of allogeneic immune cell-based therapies, such as CAR-T.

Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ended December 31, 2020 and provide an operational update